Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Coivas vs Elevate Health

Coivas
Graded #194

Higher grade

vs+7.700000000000003
Elevate Health
Graded #371

Lower grade

The verdict

Coivas takes it — 66.2/100 to 58.5/100.

Coivas grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Coivas is an all-inclusive GLP-1 telehealth service operated by WellVi LLC (d/b/a Coivas) with prescriptions through Arora Health & Aesthetics, LLC.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoivas +38
70
32
Dose & formulationElevate Health +13
64
77
Clinical oversightCoivas +5
84
79
Labs & monitoringElevate Health +9
54
63
FulfillmentCoivas +13
78
65
Contract termsElevate Health +5
20
25
Coivas · left barElevate Health · right bar

The numbers

MetricCoivasElevate Health
WeighScore66.2/10058.5/100
GradeCC
Scorecard rank#194#371
Semaglutide$149/mo (quarterly plan, compounded)$299/mo (compounded)
Tirzepatide$229/mo (quarterly plan, compounded)$399/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Coivas

Graded #194 · C

Strengths

  • All-inclusive pricing: one price covers doctor consult, prescription, shipping and support
  • Compounded semaglutide from $149/mo and tirzepatide from $229/mo on the quarterly plan
  • Names its clinical provider (Arora Health & Aesthetics, LLC) and cites USP 797 / NABP-accredited pharmacies
  • Available in all 50 states; 24/7 support; HSA/FSA eligible; money-back guarantee
  • Most patients approved in under 2 hours; refund if no provider visit or prescription occurs

Where it loses points

  • Dispensing pharmacies described only by category (503A/503B, NABP-accredited) - not named individually
  • Lower quarterly headline price requires a 3-month commitment; monthly plan costs more ($179/$289)
  • Money-back guarantee has strict adherence/verification conditions and no partial/prorated refunds
  • No brand-name Wegovy/Zepbound/Mounjaro/Ozempic - compounded injectable only; binding NY arbitration
Elevate Health

Graded #371 · C

Strengths

  • Compounded semaglutide ($299/mo, from $158/mo on 12-month) and tirzepatide ($399/mo, from $248/mo)
  • Also offers brand-name Zepbound (tirzepatide) plus NAD+, B12, and glutathione add-ons
  • All supplies included; Affirm/Klarna payment plans available
  • Full refund if you are not approved
  • 35,000+ patients served

Where it loses points

  • Month-to-month pricing is high ($299 sema / $399 tirz); the low rates require a 12-month commitment
  • Pharmacy partner and prescribing medical group not named
  • States of operation not published
  • Not LegitScript-certified (no certification displayed)
  • No standalone Terms of Service page (only Privacy, HIPAA, and a safety-information page)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard